Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 21, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 24, 2026
OfficerIndirect holdingGrant / award
Context
Classification
grant award
Derivative acquisition at no reported price
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-173766
Filed / recorded
Apr 24, 2026, 12:20 AM UTC
Added to OQRO
Oct 8, 2026, 8:56 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
BELITE BIO, INC
Issuer CIK
1889109
Ticker
BLTE
Reporting person
Hendrik Peter Scholl
Relationship
Officer
Officer title
Chief Medical Officer
Security
Stock Option (right to buy)
Table
Derivative (Table II)
Transaction date
Apr 21, 2026
Transaction code
J
Shares / units
10,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
10,000
Ownership form
Indirect — By Bioptima Ltd.
Amendment
No
Footnotes from the filing
On October 7, 2025, the reporting person was granted an option which shall vest upon satisfaction of certain performance criteria. Such performance criteria was met on 04/21/2026, resulting in vesting of the option as to 10,000 ordinary shares.
2 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 15, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
3 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 15, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.